AC1Q3QWB from MedChemExpress

Supplier Page

Supplier Page from
MedChemExpress for
AC1Q3QWB

Description

AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-EZH2 interaction and enhances the efficacy of Tazemetostat in endometrial cancer[1]